🇺🇸 Ketorolac 30 mg in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alopecia — 2 reports (16.67%)
  2. Haematemesis — 2 reports (16.67%)
  3. Alanine Aminotransferase Increased — 1 report (8.33%)
  4. Anaphylactic Shock — 1 report (8.33%)
  5. Angioedema — 1 report (8.33%)
  6. Antibiotic Level Above Therapeutic — 1 report (8.33%)
  7. Anxiety — 1 report (8.33%)
  8. Aspartate Aminotransferase Increased — 1 report (8.33%)
  9. Aspiration — 1 report (8.33%)
  10. Aura — 1 report (8.33%)

Source database →

Ketorolac 30 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ketorolac 30 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ketorolac 30 mg in United States?

Cairo University is the originator. The local marketing authorisation holder may differ — check the official source linked above.